LCD and Article Updates for January and February 2021

Billing and Coding: Filgrastim, Pegfilgrastim, Tbo-filgrastim and biosimilars (A52408)
HCPCS code Q5122 has been added to the "CPT/HCPCS Codes" section.

Billing and Coding: Intravenous Immune Globulin (IVIG) (A52446)
HCPCS code C9072 has been added to the "CPT/HCPCS Codes" section.

Billing and Coding: Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography) (A56726)
Due to the 2021 annual HCPCS update, the descriptors for CPT codes 92227 and 92228 have been revised.

Billing and Coding: Rituximab, biosimilars and Rituximab and hyaluronidase human (Rituxan Hycela™) (A52452)
The article has been updated to add rituximab-arrx (Riabni™) effective for dates of service on or after 12/17/2020. HCPCS code C9399 and J3590 have been added to the “CPT/HCPCS Codes Group 1 Paragraph” section to report rituximab-arrx (Riabni™). HCPCS codes C9399 and J3590 have been added to the “CPT/HCPCS Codes” section. References to rituximab-arrx (Riabni™) have been added throughout the article.

Self-Administered Drug Exclusion List: Medical Policy Article (A53021 JK) and (A53022 J6)
Based on Transmittal 10463 (CR11880) (Billing for Home Infusion Therapy Services On or After 1/1/2021), which includes changes to the Medicare home infusion therapy services benefit, the article has been updated to move Hizentra® (J1559) to the Non-Excluded CPT/HCPCS Codes-Table with an Exclusion End Date of 12/31/2020.

Posted 1/27/2021